Astria Therapeutics to present at upcoming American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Astra Therapeutics today announced that it will present final STAR-0215 Phase 1a healthy subject data at the upcoming American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting in Washington, D.C. on February 23, 2024 at 3:15pm Eastern Standard Time (EST).
Dr. William Lumry, M.D., Clinical Professor of Internal Medicine at the University of Texas Health Science Center at Dallas, will present a poster titled: “Updated Results from a Phase 1a Trial of STAR-0215 for Hereditary Angioedema” at 3:15pm EST in the Convention Center, Level 2, Hall D, poster number 032.
(Source: Astria)
